Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.
Article Details
- CitationCopy to clipboard
Krell JM
Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.
J Am Acad Dermatol. 2006 Jun;54(6):1099-101.
- PubMed ID
- 16713481 [ View in PubMed]
- Abstract
This article reports on the combined use of alefacept and etanercept in 3 patients whose psoriasis failed to respond adequately to etanercept. All patients maintained improvement for at least 8 weeks after completing 12 weeks of alefacept. No adverse events or infections were reported, and CD4+ T-cell counts remained above normal limits.
DrugBank Data that Cites this Article
- Drugs